Evofem Clinical Metadata Governance And Trial Equipment & Supplies
2 equipment items found
by:Evofem Biosciences, Inc. based inSan Diego, CALIFORNIA (USA)
We are collaborating with Orion Biotechnology to evaluate the compatibility and stability of Orion’s novel CCR5 antagonist, OB-002, in Phexxi with the goal of developing a Multipurpose Prevention Technology (MPT) product candidate for indications including the prevention of human immunodeficiency virus (HIV) in women. This collaboration will focus on determining compatibility and stability ...
by:Evofem Biosciences, Inc. based inSan Diego, CALIFORNIA (USA)
EVO100 (the investigational name for Phexxi) is in development for two potential new indications, the prevention of urogenital chlamydia and urogenital gonorrhea in women, leveraging its vaginal pH modulator mechanism of action. Infection with these bacterial pathogens hEVO100 (the investigational name for Phexxi) is in development for two potential new indications, the prevention of urogenital ...